GE HealthCare Technologies Product — Effects of cash flow hedges decreased by 64.3% to $5.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 350.0%, from -$2.00M to $5.00M. Over 4 years (FY 2021 to FY 2025), Product — Effects of cash flow hedges shows an upward trend with a 22.5% CAGR.
Fluctuations reflect the effectiveness of the company's currency risk management strategy rather than core operational performance.
Reflects the impact of financial instruments used to mitigate the risk of variability in cash flows associated with high...
Common in multinational corporations managing global currency exposure.
gehc_segment_product_effects_of_cash_flow_hedges| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.00M | -$2.00M | -$2.00M | $9.00M | $5.00M | $13.00M | $27.00M | $27.00M | -$5.00M | -$5.00M | $6.00M | -$1.00M | $1.00M | $3.00M | -$7.00M | -$2.00M | -$3.00M | $9.00M | $14.00M | $5.00M |
| QoQ Change | — | +0.0% | +0.0% | +550.0% | -44.4% | +160.0% | +107.7% | +0.0% | -118.5% | +0.0% | +220.0% | -116.7% | +200.0% | +200.0% | -333.3% | +71.4% | -50.0% | +400.0% | +55.6% | -64.3% |
| YoY Change | — | — | — | — | +350.0% | +750.0% | >999% | +200.0% | -200.0% | -138.5% | -77.8% | -103.7% | +120.0% | +160.0% | -216.7% | -100.0% | -400.0% | +200.0% | +300.0% | +350.0% |